Table 2. Comparison of symptoms related to chronic strongyloidiasis and baseline laboratory results.
| Parameters | Albendazol(N = 30) | Ivermectin-I(N = 31) | Ivermectin –II(N = 29) | P-value |
| Symptoms associated with strongyloidiasis, n (%) | ||||
| - Diarrhea | 14 (46.7) | 11 (35.5) | 16 (51.6) | 0.609 |
| - Abdominal pain | 3 (10) | 4 (12.9) | 6 (20.7) | 0.483 |
| - Nausea/vomiting | 4 (13.3) | 4 (12.9) | 6 (20.7) | 0.650 |
| Laboratory test, mean (SD) | ||||
| - Hematocrit, % (35–45) | 32.7 (7) | 35.4 (6) | 32 (8) | 0.132 |
| - Eosinophil count, ×106/L (<500) | 967(1,239) | 1,203(2,714) | 554(1,781) | 0.366 |
| - Total eosinophil >500/µL, n (%) | 14 (46.7) | 18 (58.1) | 13 (44.8) | 0.535 |
| - AST, U/L (0–37) | 45(43) | 45(60) | 38(34) | 0.805 |
| - ALT, U/L (0–40) | 38(31) | 42(38) | 38(47) | 0.924 |
| - Creatinine, mg/dL (0.8–1.2) | 1.2(0.5) | 1.1(0.9) | 0.8(0.8) | 0.933 |